DRIEHAUS CAPITAL MANAGEMENT LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,489,000
+76.8%
343,000
-20.9%
0.02%
-37.5%
Q3 2014$842,000
-50.2%
433,766
-6.8%
0.03%
-41.8%
Q2 2014$1,690,000
-46.1%
465,509
-42.4%
0.06%
-44.4%
Q1 2014$3,138,000808,7380.10%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders